Trials / Completed
CompletedNCT01625377
A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients
A National, Multi-center, Randomized, Open Label Study to Evaluate the Efficacy and Safety of Everolimus Combined With Enteric-coated Mycophenolate Sodium Compared to the Standard Treatment Combining Tacrolimus and Enteric-coated Mycophenolate Sodium in de Novo Liver Transplant Recipients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 188 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aims of the study was to evaluate the safety and efficacy of early introduction one month post-transplantation of everolimus associated to EC-MPS with tacrolimus discontinuation in de novo liver transplant recipients and to evaluate if it leads to a better renal function 6 month post-transplantation compared to standard treatment associating tacrolimus and EC-MPS. The renal function was estimated by glomerular filtration rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tacrolimus | Arm 1 : tacrolimus (C0 6-10 ng/ml) from D3-D5 post-transplantation to month 6 post-transplantation. Arm 2 : tacolimus (C0 6-10 ng/ml) from D3-D5 post-transplantation to 16 weeks post-transplantation at the latest. |
| DRUG | everolimus | Arm 1: no everolimus Arm 2: everolimus (C0 6-10 ng/ml) from randomization to month 6 post-transplantation |
| DRUG | Basiliximab | Basiliximab was supplied to the participating centers as marketed, i.e. in packs containing one vial of 20-mg powder, and water for injection (WFI). 20 mg at D0 and D4 |
| DRUG | Mycophenolic Acid | Dose of 1440 mg/day from transplantation to month 6 post- transplantation |
| DRUG | Corticosteroids | Administration of oral corticosteroid therapy was at the discretion of the centers according to their usual practice |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2012-06-21
- Last updated
- 2016-04-27
- Results posted
- 2016-04-27
Locations
14 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01625377. Inclusion in this directory is not an endorsement.